Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s stock price was up 7.4% on Wednesday . The company traded as high as $160.0390 and last traded at $160.0390. Approximately 5 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 673 shares. The stock had previously closed at $148.9590.
Merck KGaA Price Performance
The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm has a market cap of $20.74 billion, a price-to-earnings ratio of 24.50 and a beta of 0.96. The stock has a 50-day moving average of $142.91 and a two-hundred day moving average of $142.81.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- 3 Stocks to Watch If the Strait of Hormuz Reopens
- Draining the Tank: Big Oil Runs on Fumes
- Microsoft’s Xbox Problem Is Bigger Than a Console War
- Dave & Buster’s Q1 Miss Raises the Stakes for Its Turnaround Plan
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
